SPARK Neuro is a leading neuroscience company that quantifies brain data for better clinical care and therapeutic discovery.
Spark Neuro has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in February 2023.
Spark Neuro's investors include AngelList, R136 Ventures, King River Capital, Thiel Capital, MBX Capital.
Spark Neuro is headquartered in New York, United States.
SPARK Neuro is a leading neuroscience company that quantifies brain data for better clinical care and therapeutic discovery.
Spark Neuro is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spark Neuro — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/spark-neuro. Accessed November 12, 2026.
VCBacked. (2023). Spark Neuro — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/spark-neuro
{{cite web |title=Spark Neuro — Funding & Investors |url=https://www.vcbacked.co/company/spark-neuro |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Spark Neuro? Request a listing update